50-32-231. Criteria for placement of drug in Schedule V. The board shall place a drug in Schedule V if it finds that:
     (1) the drug has low potential for abuse relative to the controlled drugs listed in Schedule IV;
     (2) the drug has currently accepted medical use in treatment in the United States; and
     (3) the drug has limited physical dependence or psychological dependence liability relative to the dangerous drugs listed in Schedule IV.

     History: En. Sec. 12, Ch. 412, L. 1973; R.C.M. 1947, 54-312.